Cargando…
Atrial-like Engineered Heart Tissue: An In Vitro Model of the Human Atrium
Cardiomyocytes (CMs) generated from human induced pluripotent stem cells (hiPSCs) are under investigation for their suitability as human models in preclinical drug development. Antiarrhythmic drug development focuses on atrial biology for the treatment of atrial fibrillation. Here we used recent ret...
Autores principales: | Lemme, Marta, Ulmer, Bärbel M., Lemoine, Marc D., Zech, Antonia T.L., Flenner, Frederik, Ravens, Ursula, Reichenspurner, Hermann, Rol-Garcia, Miriam, Smith, Godfrey, Hansen, Arne, Christ, Torsten, Eschenhagen, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294072/ https://www.ncbi.nlm.nih.gov/pubmed/30416051 http://dx.doi.org/10.1016/j.stemcr.2018.10.008 |
Ejemplares similares
-
Human iPSC-derived cardiomyocytes cultured in 3D engineered heart tissue show physiological upstroke velocity and sodium current density
por: Lemoine, Marc D., et al.
Publicado: (2017) -
Chronic intermittent tachypacing by an optogenetic approach induces arrhythmia vulnerability in human engineered heart tissue
por: Lemme, Marta, et al.
Publicado: (2020) -
Low Resting Membrane Potential and Low Inward Rectifier Potassium Currents Are Not Inherent Features of hiPSC-Derived Cardiomyocytes
por: Horváth, András, et al.
Publicado: (2018) -
Blinded Contractility Analysis in hiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial Trabeculae
por: Mannhardt, Ingra, et al.
Publicado: (2017) -
Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?
por: Christ, Torsten, et al.
Publicado: (2021)